Cargando…
933. Cured vs. Not Yet Treated: Population Differences for HIV/HCV Co-infected Patients Navigating the HCV Care Cascade in 11 Connecticut Clinics
BACKGROUND: Hepatitis C (HCV) care cascades for persons with HIV/HCV co-infection are hampered by incomplete HCV surveillance data, lack of standardized matching algorithms, and incomplete ability to determine HCV treatment status from surveillance alone. However, client-level data from individual c...
Autores principales: | Brooks, Ralph P, Wegener, Maximilian D, Speers, Suzanne, Sideleau, Robert J, Nichols, Lisa G, Villanueva, Merceditas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777100/ http://dx.doi.org/10.1093/ofid/ofaa439.1119 |
Ejemplares similares
-
932. Creating a Statewide HCV Treatment Cascade for HIV/HCV Co-Infected Persons Using a Partnership with DPH
por: Wegener, Maximilian D, et al.
Publicado: (2020) -
1483. Real-time Creation of HCV Treatment Cascades in Clinics to Improve HCV Treatment Rates Among Patients with HIV/HCV Co-infection
por: Wegener, Maximilian D, et al.
Publicado: (2023) -
957. Efficacy of Using Disease Intervention Specialists (DIS) to Re-engage Out of Care HIV/HCV Co-Infected Persons into HCV Treatment
por: Wegener, Maximilian D, et al.
Publicado: (2020) -
2510. Adapting the CDC HCV viral clearance cascade methodology for persons with HIV (PWH) and HCV co-infection in 5 Health Department Jurisdictions in the US
por: Wegener, Maximilian D, et al.
Publicado: (2023) -
Perceptions Towards HCV Treatment with Direct Acting Antivirals (DAAs): A Qualitative Analysis with Persons with HIV/HCV Co-infection Who Delay or Refuse Treatment
por: Brothers, Sarah, et al.
Publicado: (2022)